- Type / Class
- Equity / Common Stock
- Shares outstanding
- 28,736,767
- Total 13F shares
- 35,002
- Share change
- -63,659
- Total reported value
- $2,261,358
- Price per share
- $64.22
- Number of holders
- 16
- Value change
- -$8,381,167
- Number of buys
- 8
- Number of sells
- 11
Quarterly Holders Quick Answers
What is CUSIP 81663L200?
CUSIP 81663L200 identifies WGS - GeneDx Holdings Corp. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 81663L200:
Top shareholders of WGS - GeneDx Holdings Corp. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Corvex Management LP |
13F
3/4/5
|
Company · Director, 10%+ Owner |
11%
|
3,058,629
|
$397,805,288 | — | 31 Dec 2025 | |
| Casdin Capital, LLC |
13F
3/4/5
|
Company · Director, 10%+ Owner |
11%
from 3/4/5
|
3,007,164
|
$391,111,750 | — | 31 Dec 2025 | |
| CMLS Holdings LLC |
13D/G
|
Keith A. Meister |
12%
|
3,630,826
|
$375,826,799 | -$48,159,994 | 22 Aug 2025 | |
| Eli Casdin |
3/4/5
|
Director, 10%+ Owner |
14%
|
3,880,073
|
$337,217,143 | — | 18 Jun 2025 | |
| Keith A. Meister |
3/4/5
|
Director, 10%+ Owner |
11%
|
3,248,279
|
$266,598,662 | +$22,069,081 | 03 Mar 2026 | |
| BlackRock, Inc. |
13F
|
Company |
5.4%
|
1,560,094
|
$202,905,825 | — | 31 Dec 2025 | |
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI |
3/4/5
13D/G
|
10%+ Owner |
4.9%
from 13D/G
|
2,719,692
|
$192,487,561 | — | 15 Nov 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
13D/G
|
Company · THE GOLDMAN SACHS GROUP, INC. |
3.9%
from 13D/G
|
1,220,502
|
$158,738,491 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.1%
|
1,189,069
|
$154,650,315 | — | 31 Dec 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
3.8%
|
1,092,988
|
$142,154,023 | — | 31 Dec 2025 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13D/G
13F
|
Company |
4.3%
|
1,235,681
|
$133,132,271 | -$42,634,981 | 30 Sep 2025 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
3.5%
|
1,018,261
|
$132,435,026 | — | 31 Dec 2025 | |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC |
13F
13D/G
|
Company |
3%
from 13D/G
|
920,587
|
$119,731,545 | — | 31 Dec 2025 | |
| ORACLE INVESTMENT MANAGEMENT INC |
13F
|
Company |
3.1%
|
884,654
|
$115,058,099 | — | 31 Dec 2025 | |
| FMR LLC |
13F
13D/G
|
Company |
0.6%
from 13D/G
|
832,738
|
$108,305,906 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
2.7%
|
786,466
|
$102,287,768 | — | 31 Dec 2025 | |
| OPKO HEALTH, INC. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,646,972
|
$91,295,123 | — | 15 Aug 2024 | |
| ARK Investment Management LLC |
13F
|
Company |
2.1%
|
604,561
|
$78,629,240 | — | 31 Dec 2025 | |
| Zweig-DiMenna Associates LLC |
13F
|
Company |
2.1%
|
597,825
|
$77,753,120 | — | 31 Dec 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2%
|
584,150
|
$75,975,000 | — | 31 Dec 2025 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
1.8%
|
518,304
|
$67,411,000 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.8%
|
506,091
|
$65,822,282 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
504,567
|
$65,635,200 | — | 31 Dec 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
1.8%
|
505,341
|
$65,531,959 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.6%
|
456,258
|
$59,340,915 | — | 31 Dec 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
—
mixed-class rows
|
657,771
mixed-class rows
|
$53,854,000 | — | 31 Dec 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.4%
|
395,323
|
$51,415,709 | — | 31 Dec 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.3%
|
384,750
|
$50,040,585 | — | 31 Dec 2025 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
1.3%
|
381,725
|
$49,647,154 | — | 31 Dec 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
1.3%
|
381,725
|
$49,647,154 | — | 31 Dec 2025 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1.1%
|
302,149
|
$39,297,496 | — | 31 Dec 2025 | |
| Capital International Investors |
13F
|
Company |
0.99%
|
283,248
|
$36,839,235 | — | 31 Dec 2025 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.93%
|
266,636
|
$34,678,678 | — | 31 Dec 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.9%
|
258,745
|
$33,652,375 | — | 31 Dec 2025 | |
| GAGNON SECURITIES LLC |
13F
|
Company |
0.88%
|
253,534
|
$32,974,632 | — | 31 Dec 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.88%
|
253,454
|
$32,964,227 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.79%
|
227,586
|
$29,599,834 | — | 31 Dec 2025 | |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. |
13F
|
Company |
0.79%
|
227,284
|
$29,561,000 | — | 31 Dec 2025 | |
| Joshua Ruch |
3/4/5
|
Director |
0.65%
|
185,990
|
$29,229,921 | -$6,093,967 | 24 Nov 2025 | |
| Katherine Stueland |
3/4/5
|
CHIEF EXECUTIVE OFFICER, Director |
—
mixed-class rows
|
251,514
mixed-class rows
|
$29,178,085 | -$14,923,454 | 26 Mar 2026 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.72%
|
205,895
|
$26,778,704 | — | 31 Dec 2025 | |
| Science & Technology Partners, L.P. |
13F
|
Company |
0.7%
|
201,264
|
$26,176,396 | — | 31 Dec 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.69%
|
198,926
|
$25,872,315 | — | 31 Dec 2025 | |
| OBERWEIS ASSET MANAGEMENT INC/ |
13F
|
Company |
0.69%
|
198,770
|
$25,852,026 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.69%
|
198,621
|
$25,832,646 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.63%
|
182,351
|
$23,716,572 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.62%
|
177,030
|
$23,024,522 | — | 31 Dec 2025 | |
| NEXT CENTURY GROWTH INVESTORS LLC |
13F
|
Company |
0.6%
|
173,411
|
$22,553,834 | — | 31 Dec 2025 | |
| Alamea Verwaltungs GmbH |
13F
|
Company |
0.65%
|
185,989
|
$21,115,747 | — | 31 Dec 2025 | |
| ASHFORD CAPITAL MANAGEMENT INC |
13F
|
Company |
0.46%
|
132,326
|
$17,210,320 | — | 31 Dec 2025 |
Institutional Holders of GeneDx Holdings Corp. - Common Stock (WGS) as of Q1 2026
As of 31 Mar 2026,
GeneDx Holdings Corp. - Common Stock (WGS) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,002 shares.
The largest 10 holders included
THOMPSON DAVIS & CO., INC., WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, Perigon Wealth Management, LLC, NBC SECURITIES, INC., OP Asset Management Ltd, Versant Capital Management, Inc, Capital Advisors, Ltd. LLC, GAMMA Investing LLC, Bayforest Capital Ltd, and WOLFF WIESE MAGANA LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
283
Q1 2026 holders
16
Holder diff
-267
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.